Intellia Therapeutics Inc buy JPMorgan Chase & Co.
Start price
12.08.24
/
50%
€19.93
Target price
12.08.25
€50.28
Performance (%)
-1.30%
Price
20:05
€19.67
Summary
This prediction is currently active. With a performance of -1.30%, the BUY prediction for Intellia Therapeutics Inc by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 12.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Intellia Therapeutics Inc | -1.30% |
iShares Core DAX® | 2.722% |
iShares Nasdaq 100 | 4.546% |
iShares Nikkei 225® | 6.353% |
iShares S&P 500 | 3.194% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at JPMorgan Chase & Co. from $61.00 to $55.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€33.87
31.03.23
31.03.23
€72.55
31.03.24
31.03.24
-24.45%
01.04.24
01.04.24